[Evaluation of Ki-67 expression in recurrent cases of cholesteatoma]. 2007

Arif Sanli, and Ilter Tezer, and Mustafa Paksoy, and Sedat Aydin, and Umit Hardal, and Nagehan Barşik Ozdemir
Department of Otolaryngology, Dr. Lütfi Kirdar Kartal Training and Research Hospital, Istanbul, Turkey.

OBJECTIVE Recurrences are still a challenge despite appropriate techniques in cholesteatoma surgery. This study was designed to evaluate the level of Ki-67 expression in recurrent cases of cholesteatoma. METHODS The study included 32 patients (18 males, 14 females; mean age 34 years; range 12 to 63 years) who underwent surgery for otitis media. Of these, 19 patients had cholesteatoma, and eight patients had recurrent cholesteatoma. Five patients who underwent tympanoplasty for chronic otitis media comprised the control group. All the patients with cholesteatoma underwent radical mastoidectomy. At surgery, tissue samples of cholesteatoma were taken and prepared for immunohistochemical staining. In controls, retroauricular skin samples were used. The two patient groups with cholesteatoma were compared with respect to Ki-67 expression. RESULTS Increased cellular proliferation was detected in both groups of cholesteatoma. No significant difference was found between two cholesteatoma groups with respect to Ki-67 staining (p>0.05). Compared to the controls, patients with cholesteatoma and those with recurrent cholesteatoma had significantly higher levels of Ki-67 staining (p<0.05 and p<0.01, respectively). CONCLUSIONS Our results suggest that, despite a higher degree of proliferation in recurrent cholesteatoma cases, treatment failures may be mainly associated with the surgical technique, accompanying infections, and the type of cholesteatoma.

UI MeSH Term Description Entries
D007150 Immunohistochemistry Histochemical localization of immunoreactive substances using labeled antibodies as reagents. Immunocytochemistry,Immunogold Techniques,Immunogold-Silver Techniques,Immunohistocytochemistry,Immunolabeling Techniques,Immunogold Technics,Immunogold-Silver Technics,Immunolabeling Technics,Immunogold Silver Technics,Immunogold Silver Techniques,Immunogold Technic,Immunogold Technique,Immunogold-Silver Technic,Immunogold-Silver Technique,Immunolabeling Technic,Immunolabeling Technique,Technic, Immunogold,Technic, Immunogold-Silver,Technic, Immunolabeling,Technics, Immunogold,Technics, Immunogold-Silver,Technics, Immunolabeling,Technique, Immunogold,Technique, Immunogold-Silver,Technique, Immunolabeling,Techniques, Immunogold,Techniques, Immunogold-Silver,Techniques, Immunolabeling
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D012008 Recurrence The return of a sign, symptom, or disease after a remission. Recrudescence,Relapse,Recrudescences,Recurrences,Relapses
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D016022 Case-Control Studies Comparisons that start with the identification of persons with the disease or outcome of interest and a control (comparison, referent) group without the disease or outcome of interest. The relationship of an attribute is examined by comparing both groups with regard to the frequency or levels of outcome over time. Case-Base Studies,Case-Comparison Studies,Case-Referent Studies,Matched Case-Control Studies,Nested Case-Control Studies,Case Control Studies,Case-Compeer Studies,Case-Referrent Studies,Case Base Studies,Case Comparison Studies,Case Control Study,Case Referent Studies,Case Referrent Studies,Case-Comparison Study,Case-Control Studies, Matched,Case-Control Studies, Nested,Case-Control Study,Case-Control Study, Matched,Case-Control Study, Nested,Case-Referent Study,Case-Referrent Study,Matched Case Control Studies,Matched Case-Control Study,Nested Case Control Studies,Nested Case-Control Study,Studies, Case Control,Studies, Case-Base,Studies, Case-Comparison,Studies, Case-Compeer,Studies, Case-Control,Studies, Case-Referent,Studies, Case-Referrent,Studies, Matched Case-Control,Studies, Nested Case-Control,Study, Case Control,Study, Case-Comparison,Study, Case-Control,Study, Case-Referent,Study, Case-Referrent,Study, Matched Case-Control,Study, Nested Case-Control

Related Publications

Arif Sanli, and Ilter Tezer, and Mustafa Paksoy, and Sedat Aydin, and Umit Hardal, and Nagehan Barşik Ozdemir
June 1993, Archives of otolaryngology--head & neck surgery,
Arif Sanli, and Ilter Tezer, and Mustafa Paksoy, and Sedat Aydin, and Umit Hardal, and Nagehan Barşik Ozdemir
November 2000, The Laryngoscope,
Arif Sanli, and Ilter Tezer, and Mustafa Paksoy, and Sedat Aydin, and Umit Hardal, and Nagehan Barşik Ozdemir
February 2007, Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology,
Arif Sanli, and Ilter Tezer, and Mustafa Paksoy, and Sedat Aydin, and Umit Hardal, and Nagehan Barşik Ozdemir
April 2019, The journal of international advanced otology,
Arif Sanli, and Ilter Tezer, and Mustafa Paksoy, and Sedat Aydin, and Umit Hardal, and Nagehan Barşik Ozdemir
January 2005, American journal of otolaryngology,
Arif Sanli, and Ilter Tezer, and Mustafa Paksoy, and Sedat Aydin, and Umit Hardal, and Nagehan Barşik Ozdemir
December 2021, Cell death and differentiation,
Arif Sanli, and Ilter Tezer, and Mustafa Paksoy, and Sedat Aydin, and Umit Hardal, and Nagehan Barşik Ozdemir
July 2021, The journal of international advanced otology,
Arif Sanli, and Ilter Tezer, and Mustafa Paksoy, and Sedat Aydin, and Umit Hardal, and Nagehan Barşik Ozdemir
May 1998, Journal of neuro-oncology,
Arif Sanli, and Ilter Tezer, and Mustafa Paksoy, and Sedat Aydin, and Umit Hardal, and Nagehan Barşik Ozdemir
October 2018, BMC veterinary research,
Arif Sanli, and Ilter Tezer, and Mustafa Paksoy, and Sedat Aydin, and Umit Hardal, and Nagehan Barşik Ozdemir
October 2016, Translational lung cancer research,
Copied contents to your clipboard!